Finance

Lists
Why is NVCT up ८.९२%?
Dive Deeper
NVCT:NASDAQ
Nuvectis Pharma Inc
US$ २०.६३
+८.९२%
(+१.६९) 1D
अक्टोबर २०, १५:५५:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NVCT...
Open
US$ १९.०९
High
US$ २०.८७
Low
US$ १७.८५
Mkt. cap
६७.२२ करोड
Avg. vol.
१.९९ लाख
Volume
९७.१२ हजार
52-wk high
US$ २९.२८
52-wk low
US$ ५.५५
EPS
-US$ १.३१
Beta
-०.२४
Shares outstanding
३.२६ करोड
No. of employees
१६
Open
US$ १९.०९
High
US$ २०.८७
Low
US$ १७.८५
Mkt. cap
६७.२२ करोड
Avg. vol.
१.९९ लाख
Volume
९७.१२ हजार
52-wk high
US$ २९.२८
52-wk low
US$ ५.५५
EPS
-US$ १.३१
Beta
-०.२४
Shares outstanding
३.२६ करोड
No. of employees
१६
News stories
From web sources and news partners
About Nuvectis Pharma Inc
CEO-
Employees१६
Founded२०२०
HeadquartersFort Lee, न्यु जर्सी, संयुक्त राज्य अमेरिका
Sector-
Analyst ratings
Based on 4 analysts giving stock ratings to NVCT in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for NVCT in the last 3 months.
Highest
Current US$ २०.६३
US$ ३९.०० (+८९.०५%)
Average
US$ ३४.३३ (+६६.४१%)
Lowest
US$ ३०.०० (+४५.४२%)
Analyst
Recommendation
Action
Price target
Projected
Date
Naz Rahman
Maxim Group
Buy
Reiterated
US$ ३०.००
+४५.४%
09/25/2026
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
US$ ३९.००
+८९%
09/24/2026
Pete Stavropoulos
Cantor Fitzgerald
Buy
Initiated
-
-
08/24/2026
Christopher Liu
Lucid Capital
Buy
Maintained
US$ ३४.००
+६४.८%
08/05/2026
Jonathan Aschoff
Roth MKM
Buy
Reiterated
US$ ३३.००
+६०%
07/06/2026
Unknown Analyst
Roth MKM
Buy
Maintained
US$ २०.००
-३.१%
06/23/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
५७.७४ लाख
५०.८६ लाख
४१.०६ लाख
४६.८४ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२०.२० लाख
२५.३१ लाख
२१.५४ लाख
२५.१३ लाख
Operating expense
७७.९४ लाख
७६.१७ लाख
६२.६० लाख
७१.९७ लाख
Total operating expenses
७७.९४ लाख
७६.१७ लाख
६२.६० लाख
७१.९७ लाख
Operating income
-७७.९४ लाख
-७६.१७ लाख
-६२.६० लाख
-७१.९७ लाख
Other non operating income
-
-
-
-
EBT including unusual items
-७४.६२ लाख
-७३.१४ लाख
-६०.५० लाख
-७०.२० लाख
EBT excluding unusual items
-७४.६२ लाख
-७३.१४ लाख
-६०.५० लाख
-७०.२० लाख
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-७४.६२ लाख
-७३.१४ लाख
-६०.५० लाख
-७०.२० लाख
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
३.३२ लाख
३.०३ लाख
२.१० लाख
१.७७ लाख
Interest expense
-
-
-
-
Net interest expenses
३.३२ लाख
३.०३ लाख
२.१० लाख
१.७७ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू